Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,578 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Favorable prognostic impact of phosphatase and tensin homolog alterations in wild-type isocitrate dehydrogenase and telomerase reverse transcriptase promoter glioblastoma.
Higa N, Akahane T, Yokoyama S, Makino R, Yonezawa H, Uchida H, Takajo T, Kirishima M, Hamada T, Noguchi N, Otsuji R, Kuga D, Nagasaka S, Yamahata H, Yamamoto J, Yoshimoto K, Tanimoto A, Hanaya R. Higa N, et al. Among authors: yokoyama s. Neurooncol Adv. 2023 Jun 28;5(1):vdad078. doi: 10.1093/noajnl/vdad078. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37528810 Free PMC article.
Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S, Higashi M, Kitamoto S, Oeldorf M, Knippschild U, Kornmann M, Maemura K, Kurahara H, Wiest E, Hamada T, Kitazono I, Goto Y, Tasaki T, Hiraki T, Hatanaka K, Mataki Y, Taguchi H, Hashimoto S, Batra SK, Tanimoto A, Yonezawa S, Hollingsworth MA. Yokoyama S, et al. Oncotarget. 2016 Jul 5;7(27):42553-42565. doi: 10.18632/oncotarget.9924. Oncotarget. 2016. PMID: 27283771 Free PMC article.
Immunohistochemical expression of mucin antigens in gallbladder adenocarcinoma: MUC1-positive and MUC2-negative expression Is associated with vessel invasion and shortened survival.
Hiraki T, Yamada S, Higashi M, Hatanaka K, Yokoyama S, Kitazono I, Goto Y, Kirishima M, Batra SK, Yonezawa S, Tanimoto A. Hiraki T, et al. Among authors: yokoyama s. Histol Histopathol. 2017 Jun;32(6):585-596. doi: 10.14670/HH-11-824. Epub 2016 Sep 27. Histol Histopathol. 2017. PMID: 27672051
TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer.
Yokoyama S, Higashi M, Tsutsumida H, Wakimoto J, Hamada T, Wiest E, Matsuo K, Kitazono I, Goto Y, Guo X, Hamada T, Yamada S, Hiraki T, Yonezawa S, Batra SK, Hollingsworth MA, Tanimoto A. Yokoyama S, et al. Genes Cancer. 2017 Mar;8(3-4):517-527. doi: 10.18632/genesandcancer.139. Genes Cancer. 2017. PMID: 28680536 Free PMC article.
Protective Effects of Peroxiredoxin 4 (PRDX4) on Cholestatic Liver Injury.
Zhang J, Guo X, Hamada T, Yokoyama S, Nakamura Y, Zheng J, Kurose N, Ishigaki Y, Uramoto H, Tanimoto A, Yamada S. Zhang J, et al. Among authors: yokoyama s. Int J Mol Sci. 2018 Aug 24;19(9):2509. doi: 10.3390/ijms19092509. Int J Mol Sci. 2018. PMID: 30149550 Free PMC article.
Predicted Prognosis of Patients with Pancreatic Cancer by Machine Learning.
Yokoyama S, Hamada T, Higashi M, Matsuo K, Maemura K, Kurahara H, Horinouchi M, Hiraki T, Sugimoto T, Akahane T, Yonezawa S, Kornmann M, Batra SK, Hollingsworth MA, Tanimoto A. Yokoyama S, et al. Clin Cancer Res. 2020 May 15;26(10):2411-2421. doi: 10.1158/1078-0432.CCR-19-1247. Epub 2020 Jan 28. Clin Cancer Res. 2020. PMID: 31992588
3,578 results